Skip to Content


In the US, Onmel (itraconazole systemic) is a member of the drug class azole antifungals and is used to treat Aspergillosis - Aspergilloma, Aspergillosis - Invasive, Blastomycosis, Candida Urinary Tract Infection, Candidemia, Coccidioidomycosis, Cryptococcal Meningitis - Immunosuppressed Host, Cryptococcosis, Dermatophytosis, Esophageal Candidiasis, Febrile Neutropenia, Fungal Infection Prophylaxis, Histoplasmosis, Microsporidiosis, Onychomycosis - Fingernail, Onychomycosis - Toenail, Oral Thrush, Paracoccidioidomycosis, Sporotrichosis, Systemic Fungal Infection, Tinea Capitis, Tinea Versicolor and Vaginal Yeast Infection.

US matches:

Ingredient matches for Onmel


Itraconazole is reported as an ingredient of Onmel in the following countries:

  • United States

Important Notice: The international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.